This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311) Postoperative Monitoring and Telemonitoring (123) Coronary Heart Disease (81)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50091, first published .
Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Authors of this article:

Luis Gajate1 Author Orcid Image ;   Inés de la Hoz1 Author Orcid Image ;   Mercedes Espiño2 Author Orcid Image ;   Maria del Carmen Martin Gonzalez1 Author Orcid Image ;   Cristina Fernandez Martin1 Author Orcid Image ;   Ascensión Martín-Grande1 Author Orcid Image ;   Diego Parise Roux1 Author Orcid Image ;   Oscar Pastor3 Author Orcid Image ;   Judith Villahoz1 Author Orcid Image ;   Miguel Ángel Rodriguez-Gandía4 Author Orcid Image ;   Javier Nuño Vazquez5 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. de Man A, Long M, Stoppe C. Vitamin C for all?. Current Opinion in Critical Care 2024;30(4):298 View